Methyl hesperidin, with its significant antioxidant activity, has shown potential in the treatment of a variety of diseases closely related to oxidative stress, and its antioxidant effect plays a key role in the intervention of these diseases, as follows:
1. Cardiovascular Diseases
One of the core pathological mechanisms of cardiovascular diseases (e.g. hypertension, atherosclerosis, myocardial ischemia, etc.) is the enhancement of oxidative stress in the vascular endothelial cells, which results in the excessive production of reactive oxygen species (ROS), impairing vascular endothelial function, promoting lipid peroxidation and inflammatory responses.
Antioxidant mechanism: Methyl hesperidin can reduce the accumulation of lipid peroxidation products (e.g. malondialdehyde MDA) by scavenging intravascular ROS (e.g. superoxide anion, hydroxyl radicals); at the same time, it activates the Nrf2/HO-1 pathway, and enhances the activity of endogenous antioxidant enzymes (SOD, GSH-Px), which protects the vascular endothelial cells from oxidative damage and maintains the vasodilatory function (e.g. promotes the production of nitric oxide and nitric oxide). NO production).
Research evidence: animal experiments show that methyl hesperidin can reduce blood pressure in hypertensive model rats, reduce oxidative stress and thickening of the aortic wall; myocardial ischemia-reperfusion injury model, it can reduce the accumulation of ROS in cardiomyocytes, reduce the area of myocardial infarction.
2. Liver Diseases
Liver is the core organ of metabolism and detoxification in the body, which is susceptible to oxidative stress injury (e.g., pharmacological liver injury, non-alcoholic fatty liver disease, viral hepatitis, etc.), which is manifested by the enhancement of lipid peroxidation of hepatocytes and the imbalance of antioxidant system.
Antioxidant mechanism: Methyl hesperidin can neutralize ROS in hepatocytes, inhibit xanthine oxidase (XO) and other pro-oxidative enzymes, and reduce the damage of oxidative products to hepatocytes; meanwhile, it can up-regulate Nrf2 and its downstream antioxidant genes (e.g., HO-1. NQO1), enhance the antioxidant reserve of liver, and reduce the apoptosis of hepatocytes and inflammation response.
Research evidence: In the carbon tetrachloride-induced liver injury model, methylhesperidin can reduce serum aminotransferase (ALT, AST) levels, increase the activity of SOD and GSH-Px in liver tissue, reduce the MDA content, and alleviate the pathological injury of liver tissue; in the model of non-alcoholic fatty liver disease, it can inhibit hepatic lipid peroxidation, and improve the accumulation of intrahepatic fat.
3. Neurodegenerative diseases
The occurrence of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease is closely related to the over-activation of oxidative stress in the brain – excessive ROS will lead to neuronal cell membrane lipid oxidation, protein denaturation, and DNA damage, accelerating neuronal apoptosis.
Antioxidant mechanism: Methylhesperidin can penetrate the blood-brain barrier (some studies have shown that its metabolites have a certain brain targeting), scavenging ROS in the brain and reducing oxidative damage to neuronal cells; at the same time, by activating the Nrf2 pathway, it enhances the activity of antioxidant enzymes in the brain, protecting neurons from oxidative stress-induced apoptosis, and slowing down the formation of neurofibrillary tangles or Lewy bodies.
Evidence: In vitro experiments show that methyl hesperidin can reduce amyloid (Aβ)-induced neuronal ROS generation and tau protein hyperphosphorylation; in animal models, it can improve the motor function of the Parkinson’s disease model mice and reduce oxidative damage and loss of nigrostriatal dopaminergic neurons.
4. Inflammatory diseases
Chronic inflammation (e.g. rheumatoid arthritis, ulcerative colitis) is often associated with oxidative stress to form a “vicious circle” – ROS activate inflammatory pathways such as NF-κB and promote the release of inflammatory factors (TNF-α, IL-6), while Inflammation further exacerbates oxidative stress.
Antioxidant mechanism: Methyl hesperidin blocks the activation of inflammatory pathways by oxidative stress through the neutralization of ROS at the site of inflammation; at the same time, its antioxidant effect reduces neutrophil infiltration and the release of lysosomal enzymes, and attenuates tissue damage.
Evidence: In rheumatoid arthritis model, methyl hesperidin can reduce MDA content in joint fluid, enhance SOD activity, reduce synovial inflammation and bone destruction; in ulcerative colitis model, it can protect the intestinal mucosal barrier, reduce intestinal oxidative damage and secretion of inflammatory factors, alleviate the symptoms of diarrhea and mucosal ulceration.